Evolution of the Average Target: Cencora, Inc.

Evolution of the Target Price: Cencora, Inc.

Changes in Analyst Recommendations: Cencora, Inc.

27d86bc69.aHYqxNe0VHK_03-D9HnLk913BB7ErImOaoJY5W9UaFw.OBFniq_yOjCMgUfLmxSU2ewWPHCrzfDBA9Atpg4mXykQQGn8roQBFfSpHA~3c5e1673f812738052776d5cde6064d4
07-22 Baird Adjusts Price Target on Cencora to $340 From $337, Maintains Outperform Rating MT
07-21 BofA Securities Adjusts Cencora Price Target to $310 From $285 MT
07-07 Evercore ISI Adjusts Price Target on Cencora to $330 From $300 MT
06-24 Argus Adjusts Price Target on Cencora to $340 From $4000, Maintains Buy Rating MT
06-24 BofA Adjusts Price Target on Cencora to $285 From $280 MT
06-10 Barclays Cuts Cencora Price Target to $350 From $425, Maintains Overweight Rating MT
05-21 Baird Adjusts Price Target on Cencora to $337 From $339, Maintains Outperform Rating MT
05-11 Wells Fargo Adjusts Price Target on Cencora to $331 From $429 MT
05-08 McKesson's Fiscal 2027 Guidance 'Encouraging,' Cencora Selloff Overdone, Morgan Stanley Says MT
05-08 Morgan Stanley Lowers Price Target on Cencora to $342 From $400, Keeps Overweight Rating MT
05-07 UBS Adjusts Price Target on Cencora to $412 From $410, Maintains Buy Rating MT
04-28 William Blair Initiates Cencora at Market Perform MT
04-08 Evercore ISI Adjusts Price Target on Cencora to $360 From $420, Maintains Outperform Rating MT
03-19 Baird Adjusts Price Target on Cencora to $420 From $415, Maintains Outperform Rating MT
03-02 Leerink Partners Adjusts Price Target on Cencora to $447 From $410, Maintains Outperform Rating MT
02-13 Barclays Adjusts Cencora Price Target to $425 From $400, Maintains Overweight Rating MT
02-10 Wells Fargo Adjusts Price Target on Cencora to $429 From $405, Maintains Overweight Rating MT
02-10 JPMorgan Adjusts Price Target on Cencora to $419 From $417, Maintains Overweight Rating MT
02-05 Evercore ISI Adjusts Price Target on Cencora to $420 From $440, Maintains Outperform Rating MT
01-29 Cencora Shares Rise After Morgan Stanley Upgrade MT
01-29 Morgan Stanley Upgrades Cencora to Overweight From Equalweight, Adjusts PT to $400 From $361 MT
01-22 Jefferies Upgrades Cencora to Buy From Hold, Adjusts Price Target to $440 From $330 MT
01-13 Baird Adjusts Cencora Price Target to $415 From $392, Maintains Outperform Rating MT
01-05 Drug Distributors Poised for Growth Amid Emerging Risks, BofA Says MT
12-15 Baird Adjusts Cencora Price Target to $392 From $395, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+17.99%
+19.48%
+21.3%
+17.11%
+36.96%
+20.05%
+7.51%
+19.95%
+34.68%
Average +21.67%
Weighted average by Cap. +20.10%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
300.58USD
Average target price
355.83USD
Spread / Average Target
+18.38%
High Price Target
412.00USD
Spread / Highest target
+37.07%
Low Price Target
310.00USD
Spread / Lowest Target
+3.13%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Baird
BofA Securities
Evercore ISI
Argus
Barclays
Wells Fargo Securities
Morgan Stanley
UBS
William Blair & Co.
Leerink Partners
JPMorgan Chase
Jefferies & Co.
Deutsche Bank Securities
TD Cowen
Mizuho Securities
Citigroup
Nephron Research
Credit Suisse
Cowen
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
300.58USD
Average target price
355.83USD
Spread / Average Target
+18.38%

Quarterly revenue - Rate of surprise